Visualitzant Vall d'Hebron Barcelona Hospital Campus - VH per títol
Ara mostrant els elements 1622-1641 d 3559
-
Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial
(American Society of Clinical Oncology, 2022-04-10) -
ICO-ICS Praxi per al tractament de la mielofibrosi
(Institut Català de la SalutInstitut Català d'Oncologia, 2020-04) -
ICO-ICS Praxi per al tractament mèdic del càncer epitelial d'ovari
(Institut Català de la SalutInstitut Català d'Oncologia, 2017-11) -
ICO-ICS Praxis per al tractament mèdic i amb irradiació del mieloma múltiple
(Institut Català d'OncologiaInstitut Català de la Salut, 2021-03) -
Identification of 22q11.2 deletion syndrome via newborn screening for severe combined immunodeficiency: two years’ experience in Catalonia (Spain)
(Wiley Online Library, 2019-10-30) -
Identification of a Locus on the X Chromosome Linked to Familial Membranous Nephropathy
(Elsevier, 2021-06) -
Identification of a Molecularly-Defined Subset of Breast and Ovarian Cancer Models that Respond to WEE1 or ATR Inhibition, Overcoming PARP Inhibitor Resistance
(American Association for Cancer Research, 2022-10-15) -
Identification of Enhancer-Promoter Contacts in Embryoid Bodies by Quantitative Chromosome Conformation Capture (4C)
(MyJove Corporation, 2020-04-29) -
Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response
(eLife Sciences Publications, 2022-05-26)